Bluejay Diagnostics, Inc. (BJDX) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $146K. Most recent filing: Aug. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 18, 2026 filed Aug. 17, 2026 | ZEIDMAN FRED S Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Wurth Douglas Clark Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Dey Indranil President and CEO | $0 | 28,000 | +224% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Dey Svetlana Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| July 22, 2026 filed July 21, 2026 | BANK OF AMERICA CORP /DE/ 10% Owner | $0 | 0 | — | No | |
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free